Literature DB >> 22243561

Patterns of operative mortality following esophagectomy.

C Schieman1, D A Wigle, C Deschamps, F C Nichols Iii, S D Cassivi, K R Shen, M S Allen.   

Abstract

Esophagectomy has one of the highest mortality rates among all surgical procedures. We investigated the type and frequency of complications associated with perioperative mortality after esophagectomy. We performed a retrospective review of all perioperative deaths following esophagectomy for esophageal cancer at the Mayo Clinic, Rochester from 1993 through 2009. Of 1522 esophagectomies, perioperative mortality occurred in 45 (3.0%). The majority who died were male (82%); median age was 72 years (range 46-92). The median age-adjusted Charlson comorbidity score was 6. Twenty-three (51%) underwent neoadjuvant chemoradiotherapy. The type of esophagectomy was transthoracic in 27 patients (60%), transhiatal in eight (18%), tri-incisional in seven (16%), left thoracoabdominal in one (2%), and transabdominal in one (2%). A mean of 3.2 major complications occurred prior to death (median 2.5, range 1-8), with the most common being pulmonary complications occurring in 30 patients (67%) and anastomotic complications in 20 (44%). The primary underlying cause of death was pulmonary complications and anastomotic complications in 18 patients (40%) each, respectively, abdominal sepsis in three (7%), fatal hemorrhage in three (7%), and pulmonary embolism, stroke and multisystem organ failure in one each (2%), respectively. Patients died a median of 19 days (range 3-98) following esophagectomy. Most patients who died following esophagectomy experienced multiple serious complications rather than a single causative event. Major pulmonary and anastomotic complications were implicated in the vast majority of perioperative mortality, and should remain the focus of efforts to improve clinical outcomes.
© 2012 Copyright the Authors. Journal compilation © 2012, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Mesh:

Year:  2012        PMID: 22243561     DOI: 10.1111/j.1442-2050.2011.01304.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  29 in total

1.  Risk factors for pulmonary complications after esophagectomy for esophageal cancer.

Authors:  Naoya Yoshida; Masayuki Watanabe; Yoshifumi Baba; Shiro Iwagami; Takatsugu Ishimoto; Masaaki Iwatsuki; Yasuo Sakamoto; Yuji Miyamoto; Nobuyuki Ozaki; Hideo Baba
Journal:  Surg Today       Date:  2013-04-14       Impact factor: 2.549

2.  Risk factors for pulmonary morbidities after minimally invasive esophagectomy for esophageal cancer.

Authors:  Tomoyuki Uchihara; Naoya Yoshida; Yoshifumi Baba; Taisuke Yagi; Tasuku Toihata; Eri Oda; Daisuke Kuroda; Tsugio Eto; Mayuko Ohuchi; Kenichi Nakamura; Hiroshi Sawayama; Koichi Kinoshita; Masaaki Iwatsuki; Takatsugu Ishimoto; Yasuo Sakamoto; Hideo Baba
Journal:  Surg Endosc       Date:  2017-12-22       Impact factor: 4.584

3.  Significance of D-dimer-based screening for detecting pre-operative venous thromboembolism in patients with esophageal cancer after neoadjuvant chemotherapy.

Authors:  Keita Takahashi; Masayuki Watanabe; Yasukazu Kanie; Reiko Otake; Ryotaro Kozuki; Tasuku Toihata; Akihiko Okamura; Jun Kanamori; Yu Imamura
Journal:  Int J Clin Oncol       Date:  2021-03-01       Impact factor: 3.402

4.  Preoperative Smoking Cessation is Integral to the Prevention of Postoperative Morbidities in Minimally Invasive Esophagectomy.

Authors:  Naoya Yoshida; Kenichi Nakamura; Daisuke Kuroda; Yoshifumi Baba; Yuji Miyamoto; Masaaki Iwatsuki; Yukiharu Hiyoshi; Takatsugu Ishimoto; Yu Imamura; Masayuki Watanabe; Hideo Baba
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

5.  Early severe mediastinal bleeding after esophagectomy: a potentially lethal complication.

Authors:  Jeroen E H Ponten; Sylvia van der Horst; Grard A P Nieuwenhuijzen; Ted W O Elenbaas; Richard van Hillegersberg; Misha D P Luyer
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

6.  Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.

Authors:  K Fakhrian; M Oechsner; S Kampfer; T Schuster; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

7.  Original scoring system for predicting postoperative morbidity after esophagectomy for esophageal cancer.

Authors:  Naoya Yoshida; Yoshifumi Baba; Masayuki Watanabe; Satoshi Ida; Takatsugu Ishimoto; Ryuichi Karashima; Shiro Iwagami; Yu Imamura; Yasuo Sakamoto; Yuji Miyamoto; Hideo Baba
Journal:  Surg Today       Date:  2014-07-06       Impact factor: 2.549

8.  Duration of Smoking Cessation and Postoperative Morbidity After Esophagectomy for Esophageal Cancer: How Long Should Patients Stop Smoking Before Surgery?

Authors:  Naoya Yoshida; Yoshifumi Baba; Yukiharu Hiyoshi; Hironobu Shigaki; Junji Kurashige; Yasuo Sakamoto; Yuji Miyamoto; Masaaki Iwatsuki; Takatsugu Ishimoto; Keisuke Kosumi; Hidetaka Sugihara; Kazuto Harada; Ryuma Tokunaga; Daisuke Izumi; Masayuki Watanabe; Hideo Baba
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

9.  Readmission predicts 90-day mortality after esophagectomy: Analysis of Surveillance, Epidemiology, and End Results Registry linked to Medicare outcomes.

Authors:  Yinin Hu; Timothy L McMurry; George J Stukenborg; Benjamin D Kozower
Journal:  J Thorac Cardiovasc Surg       Date:  2015-08-28       Impact factor: 5.209

10.  Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer.

Authors:  Yu-Ling Chang; Yun-Fang Tsai; Yin-Kai Chao; Meng-Yu Wu
Journal:  Qual Life Res       Date:  2015-08-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.